Article
Thymidylate synthase and dihydropyrimidine dehydrogenase levels are associated with response to 5-fluorouracil in Caenorhabditis elegans.
Molecules and cells - 31 Oct 2008
Kim Seongseop, Park Dae-Hun, Shim Jaegal
Abstract excerpt
5-Fluorouracil (5-FU), a pyrimidine antagonist, has a long history in cancer treatment. The targeted pyrimidine biosynthesis pathway includes dihydropyrimidine dehydrogenase (DPD), which converts 5-FU to an inactive metabolite, and thymidylate synthase (TS), which is a major target of 5-FU. Using Caenorhabditis elegans as a model system to study the functional and resistance mechanisms of anti-cancer drugs, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
